Back
Supernus Pharmaceuticals Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
43
SUPN
Supernus Pharmaceuticals
Last Price:
37.75
Seasonality Move:
8.24%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeSupernus Pharmaceuticals Price Quote
$37.75
+3.01 (+8.66%)
(Updated: November 6, 2024 at 5:55 PM ET)
Supernus Pharmaceuticals Key Stats
Sell
43
Supernus Pharmaceuticals (SUPN)
is a Sell
Day range:
$35.33 - $38.21
52-week range:
$23.05 - $39.37
Dividend yield:
0%
P/E ratio:
1,737.00
P/S ratio:
2.97
P/B ratio:
1.9%
Volume:
938K
Avg. volume:
324.1K
1-year change:
41.91%
Market cap:
$1.9B
Revenue:
$607.5M
EPS:
$1.07
How Much Does Supernus Pharmaceuticals Make?
-
How Much Are Supernus Pharmaceuticals's Sales Annually?
SUPN Revenues are $607.5M -
How Much Profit Does Supernus Pharmaceuticals's Make A Year?
SUPN net income is $1.3M
Is Supernus Pharmaceuticals Growing As A Company?
-
What Is Supernus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.14% -
What Is Supernus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Supernus Pharmaceuticals Stock Price Performance
-
Did Supernus Pharmaceuticals Stock Go Up Last Month?
Supernus Pharmaceuticals share price went up by 8.49% last month -
Did SUPN's Share Price Rise Over The Last Year?
SUPN share price rose by 41.91% over the past 1 year
What Is Supernus Pharmaceuticals 52-Week High & Low?
-
What Is Supernus Pharmaceuticals’s 52-Week High Share Price?
Supernus Pharmaceuticals has traded as high as $39.37 over the past 52 weeks -
What Is Supernus Pharmaceuticals’s 52-Week Low Share Price?
Supernus Pharmaceuticals has traded as low as $23.05 over the past 52 weeks
Supernus Pharmaceuticals Price To Free Cash Flow
-
Is Supernus Pharmaceuticals Stock Overvalued?
Supernus Pharmaceuticals is trading at a price to free cash flow ratio of 11.24 -
Is Supernus Pharmaceuticals Stock Undervalued?
Supernus Pharmaceuticals EV to Free Cash Flow ratio is 8.81 -
What Is Supernus Pharmaceuticals’s Price Earnings Growth Ratio?
SUPN PEG ratio is 0.20 -
Is Supernus Pharmaceuticals Trading At A Premium To Earnings?
Supernus Pharmaceuticals EV to EBIT ratio is 20.90
Is It Risky To Buy Supernus Pharmaceuticals?
-
How Much Debt Does Supernus Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Supernus Pharmaceuticals Have?
Cash and short term investments quarterly total is $403.2M -
What Is Supernus Pharmaceuticals’s Book Value Per Share?
Book value per share is 18.24
Is Supernus Pharmaceuticals Cash Flow Positive?
-
What Is SUPN Cash Flow From Operations?
Cash flow from operations (TTM) is $172.5M -
What Is Supernus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $7.4M -
What Is Supernus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$243.2M
Supernus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SUPN return on invested capital is 6.32% -
What Is Supernus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 4.58% -
What Is SUPN Return On Equity?
ROE is a measure of profitability and is 6.32%
Supernus Pharmaceuticals Earnings Date & Stock Price
-
What Is Supernus Pharmaceuticals's Stock Price Today?
A single share of SUPN can be purchased today for 34.74 -
What Is Supernus Pharmaceuticals’s Stock Symbol?
Supernus Pharmaceuticals trades on the nasdaq under the ticker symbol: SUPN -
When Is Supernus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Supernus Pharmaceuticals is scheduled on February 27, 2025 -
When Is SUPN's next ex-dividend date?
Supernus Pharmaceuticals's next ex-dividend date is May 7, 2020 -
How To Buy Supernus Pharmaceuticals Stock?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Supernus Pharmaceuticals Competitors
-
Who Are Supernus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Supernus Pharmaceuticals or are related in some way:
Supernus Pharmaceuticals Dividend Yield
-
What Is SUPN Dividend Yield?
Supernus Pharmaceuticals’s dividend yield currently is 0% -
What Is Supernus Pharmaceuticals’s Payout Ratio?
Supernus Pharmaceuticals’s payout ratio is 0% -
When Did Supernus Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 7, 2024 -
What Is Supernus Pharmaceuticals’s Dividend Per Share?
Supernus Pharmaceuticals pays a dividend of $0.00 per share
Supernus Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 147.46% |
| Revenue: | 14.17% | 11.69% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 39.25 |
| Upside from Last Price: | 12.98% |